Jasper Therapeutics, Inc. (JSPR)
0.6836
-0.03
(-3.64%)
USD |
NASDAQ |
Sep 09, 12:39
Jasper Therapeutics Debt to Equity Ratio : 0.1911 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1911 |
| March 31, 2026 | 0.2226 |
| December 31, 2025 | 0.2975 |
| September 30, 2025 | 0.1472 |
| June 30, 2025 | 0.0917 |
| March 31, 2025 | 0.0613 |
| December 31, 2024 | 0.0294 |
| September 30, 2024 | 0.0247 |
| June 30, 2024 | 0.0231 |
| March 31, 2024 | 0.0225 |
| December 31, 2023 | 0.0355 |
| September 30, 2023 | 0.032 |
| June 30, 2023 | 0.0293 |
| March 31, 2023 | 0.0275 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.1014 |
| September 30, 2022 | 0.081 |
| June 30, 2022 | 0.0684 |
| March 31, 2022 | 0.0573 |
| December 31, 2021 | 0.0415 |
| September 30, 2021 | 0.0382 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.1865 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 3.242 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.80M |
| Total Liabilities (Quarterly) | 10.39M |
| Shareholders Equity (Quarterly) | 1.413M |
| Current Ratio | 1.475 |
| Net Debt Paydown Yield | 3.92% |